Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: PTC Therapeutics Inc., 3 years.
PTC Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | PTC Therapeutics Inc. | Option exercise | +1,167 | $33.63 | $39,246 |
| Mar 10, 2026 | PTC Therapeutics Inc. | Open-market sale | −1,167 | $70.00 | $81,690 |
| Mar 10, 2026 | PTC Therapeutics Inc. | Option exercise | +14,000 | $33.63 | $470,820 |
| Mar 10, 2026 | PTC Therapeutics Inc. | Open-market sale | −14,000 | $70.00 | $980,000 |
| Mar 5, 2026 | PTC Therapeutics Inc. | Open-market sale | −6,333 | $63.38 | $401,386 |
| Jan 2, 2026 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
| Nov 20, 2025 | PTC Therapeutics Inc. | Gift | −867 | — | — |
| Mar 13, 2025 | PTC Therapeutics Inc. | Open-market sale | −5,000 | $54.00 | $270,000 |
| Jan 3, 2025 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
| Feb 15, 2024 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
| Jan 5, 2023 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.